Charles Cherington bought $394k of ERNA
owner at Ernexa Therapeutics Inc.. 3,768,397 shares at an average of $0.10, traded Apr 2, 2025, filed Apr 4, 2025.
Score components
- +12Role10% owner
- +16Trade size$394k at market
- +6Relative to holdingsHoldings up 23%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-032060, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 2, 2025 | POpen-market purchase Common Stock | +3,768,397 | $0.10 | $394k | 20,401,602 | Apr 4, 2025 |
Related signals
Other insiders at Ernexa Therapeutics Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 60Notable | ERNAbuy Ernexa Therapeutics Inc. | Charles Cherington owner | $2.0M 4,000,000 shares | +144% | |
| 47Moderate | ERNAbuy Ernexa Therapeutics Inc. | Charles Cherington owner | $2.2M 21,241,163 shares | +104% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.